文献速递神经肿瘤

氨甲环酸在颅内脑膜瘤手术中效果的系统评价与Meta分析

A systematic review and meta-analysis of the effects of tranexamic acid in surgical procedure for intracranial meningioma.
PubMed 文献 · J Neurooncol · 2023-01-12

该系统评价与Meta分析纳入5项随机对照试验共321例患者,评估氨甲环酸在颅内脑膜瘤手术中的安全性与有效性。结果显示氨甲环酸与总失血量减少(SMD -1.40,95%CI [-2.49, -0.31])、麻醉时间缩短(SMD -0.36,95%CI [-0.63, -0.09])及输血需求降低(RR 0.58,95%CI [0.34, 0.99])相关。作者指出研究样本量小,需要更大样本的随机对照试验。

要点

  • 氨甲环酸与颅内脑膜瘤手术总失血量减少相关(SMD -1.40,95%CI [-2.49, -0.31])。
  • 氨甲环酸与输血需求降低相关(RR 0.58,95%CI [0.34, 0.99])。
  • 氨甲环酸与麻醉时间缩短相关(SMD -0.36,95%CI [-0.63, -0.09])。

核心结论

  • 氨甲环酸与颅内脑膜瘤手术术中失血量减少及术中、术后输血减少相关。
  • 作者指出纳入研究样本量小,需要更大样本的随机对照试验。

研究设计与样本

  • 系统评价与Meta分析,遵循PRISMA指南,检索Cochrane Central Database、WHO国际临床试验注册平台(ICTRP)、ClinicalTrials.gov和PubMed。
  • 纳入5项随机对照试验(RCT),共321例患者,干预组平均年龄47.5 ± 11.9岁,对照组平均年龄47.2 ± 11.9岁。
  • 使用JADAD量表评估纳入研究质量。

主要发现

  • 氨甲环酸组总失血量标准化均数差(SMD)为-1.40(95%CI [-2.49, -0.31])。
  • 氨甲环酸组麻醉时间SMD为-0.36(95%CI [-0.63, -0.09])。
  • 氨甲环酸组输血需求RR为0.58(95%CI [0.34, 0.99])。

局限性

  • 作者指出纳入的研究样本量小。
  • 作者指出需要更大样本的随机对照试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: During intracranial meningioma surgery, surgeons experience considerable blood loss. Tranexamic acid (TXA) is used to minimize blood loss in several neurosurgical settings. However, evidence and trials are lacking. Our objective is to establish the most recent evidence on TXA safety and efficacy in intracranial meningioma surgery. METHODOLOGY: Based upon Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), the authors collected fully published English literature on the administration of tranexamic acid for patients undergoing intracranial meningioma surgery using the keywords ["tranexamic acid" and "meningioma"] and its synonyms from Cochrane Central Database, the WHO International Clinical Trials Registry Platform (ICTRP), ClinicalTrials.gov, and PubMed. The primary outcome of the current study was total blood loss. The secondary outcomes include individuals requiring blood transfusion, anesthesia duration, surgical duration, and complication rate. Each included studies' quality was assessed using the JADAD scale. RESULTS: For qualitative and quantitative data synthesis, we included five RCTs (n = 321) with the mean age was 47.5 ± 11.9 years for the intervention group and 47.2 ± 11.9 years for the control group. Our meta-analysis showed that the administration of TXA is associated with decreased total blood loss of standardized mean difference (SMD) of -1.40 (95% CI [-2.49, -0.31]), anesthetic time SMD -0.36 (95% CI [-0.63, -0.09]), and blood transfusion requirements RR 0.58 (95% CI [0.34, 0.99]). CONCLUSIONS: The current study showed that TXA was associated with reduced intraoperative blood loss and intra- and postoperative blood transfusion. However, the studies are small. More RCT studies with a greater sample size are favorable.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Wijaya JH, July J, Quintero-Consuegra M, et al. A systematic review and meta-analysis of the effects of tranexamic acid in surgical procedure for intracranial meningioma. J Neurooncol. 2023. PMID: 36633801. doi:10.1007/s11060-023-04237-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。